NGO · France · EU Transparency Register 982539711698-79
1
position filed
in the 326 files tracked
1
legislative file
of 326 tracked
1
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 784 non-governmental organisations on this site, they rank #700 by legislative files engaged — a count of participation, not a measure of influence.
1
declared lobbying FTE
self-declared
—
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2013
in the register since
Declares membership of
Prescrire collaborates with other independent bulletins and publications
organisations
and healthcare professionals around the world.
Other teams around the globe share the principles that Prescrire upholds: centred around access to quality informatio…
Whenever possible
Prescrire works hand in hand with health professionals in other countries
participating in partnerships dedicated to the pursuit of these common goals.
Long-standing collaborations with the International Society of Drug Bulletins (ISDB) (https://www.isdbweb.org) , the…
Prescrire also helps to provide access to quality
independent information for professionals in emerging countries
via its Solidarity Support Programme.
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).
Register category
Non-governmental organisations
Registered as
Association Mieux Prescrire (AMP)
Head office
Paris Cedex 11, France
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Position paper by Prescrire about Biotech act regulation proposal Proposal for a regulation establishing a framework of measures for strengthening Union's biotechnology and biomanufacturing sectors particularly in the area of health (COM(2025) 1022 final – 2025/0406(COD)) 9 June 2026 General comment With this proposed Biotech Act regulation, the European Commission aims to strengthen the competitiveness of the…
Opening of the attached position paper · the full paper is on the Commission’s record (source link above)
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Is this your organization?
Everything on this page comes from Prescrire’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.
